In this thirteenth episode, Tom Stubbs, Co-Founder/CEO of Chronomics starts with introducing epigenetics. He describes the technology and expertise that he's brought together to create the only company in the world advancing the forefront of epigenetic biomarkers. He explains how their A.I. based health biomarker engine will be used to reduce your risk of future illness.
Lee: Hey, welcome Tom. Tom: Hey, Lee. Thank you for having me on the show. Pleasure to be here and looking forward to chatting with you. Lee: What’s the focus of Chronomics? Tom: We are very much focused on measuring health so people can avoid disease. Lee: Measuring health so that people can avoid disease, that sounds a little bit... Read MoreEpigenetic Health Monitoring to Reduce Your Future Illness Risk – EP13: Tom Stubbs (Chronomics)
In this eleventh episode, Daniel Maggs enlightens listeners as to how today we are flushing away our bodily waste daily without first capturing the highly-valuable data it contains. He details his companies forthcoming smart urine analyzer that provides personalized health advice. He shares a lot of excitement as to where home and personalized health is going.
Lee: Hello, and welcome to the show Daniel. Daniel: Thanks very much for having me Lee. Lee: I appreciate it. I can’t remember how I came across yourself. I know that I follow a partner of HAX, Benjamin Joffey who’s a friend, and I believe that bisu came through the HAX hardware accelerator program. Daniel: Yes. So Ben’s a great... Read MoreStop Flushing Terabytes of Data Down the Toilet – EP11: Daniel Maggs (Bisu)
In this eighth episode, Ben Hwang, Chairman & CEO of Profusa, provides an overview of injectable biosensors. He explains that the technology enables a model akin to getting a blood test every few seconds of our life (rather than only every few years when sick). He predicts that this “unlocked stream of biochemistry data” will become married to other data (e.g. our voice patterns) to provide a panoramic view of our health and wellbeing.
Lee: On today’s show, we have Ben Hwang, who is the Chairman and Chief Executive Officer of Profusa. From his early exposure as an undergraduate research fellow at the lab of Leroy Hood at Caltech, where the automated DNA sequencer was developed, to bringing cutting edge life science tools to the market at Life Technologies Corp, acquired by Thermo Fisher... Read MoreInjectable Biosensors – EP08: Ben Hwang (Profusa)